Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis.

Endostatin, which corresponds to the C-terminal fragment of collagen XVIII, is a potent inhibitor of angiogenesis. Fibroblast growth factor-2 (FGF-2)-induced angiogenesis in the chicken chorioallantoic membrane was inhibited by endostatin, but not by an endostatin mutant R158/270A, lacking heparin-binding ability. Endostatin was internalized by endothelial cells, but not by mouse fibroblasts. Treatment of murine brain endothelial (IBE) cells with endostatin reduced the proportion of cells in S phase, whereas growth-arrested IBE cells in collagen gels treated with endostatin displayed enhanced tubular morphogenesis. IBE cells overexpressing Shb, an adaptor protein implicated in angiostatin-induced apoptosis, displayed elevated apoptosis and decreased tubular morphogenesis in collagen gels in response to endostatin when added together with FGF-2. Induction of apoptosis was dependent on the heparin-binding ability of endostatin and the expression of Shb with a functional Src homology 2 (SH2)-domain. Endostatin treatment for 10 minutes or 24 hours induced tyrosine phosphorylation of Shb and formation of multiprotein complexes. An Shb SH2 domain fusion protein precipitated a 125-kd phosphotyrosyl protein in endostatin-treated cells. The 125-kd component either contained intrinsic tyrosine kinase activity or occurred in complex with a tyrosine kinase. In conclusion, our data show that endostatin induces tyrosine kinase activity and enhanced apoptosis in FGF-treated endothelial cells.

[1]  R. Timpl,et al.  Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin , 1999, The EMBO journal.

[2]  R. Timpl,et al.  Angiogenesis inhibitor endostatin is a distinct component of elastic fibers in vessel walls , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  J. Bajorath.  A Molecular Model of Inducible Costimulator Protein and Three-Dimensional Analysis of its Relation to the CD28 Family of T Cell-Specific Costimulatory Receptors , 1999 .

[4]  I Que,et al.  Endostatin inhibits VEGF‐induced endothelial cell migration and tumor growth independently of zinc binding , 1999, The EMBO journal.

[5]  A. Friedl,et al.  Endostatin binds to blood vessels in situ independent of heparan sulfate and does not compete for fibroblast growth factor-2 binding. , 1999, The American journal of pathology.

[6]  V. Sukhatme,et al.  Cloning, Expression, andin VitroActivity of Human Endostatin , 1999 .

[7]  D. Hanahan,et al.  Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. , 1999, Science.

[8]  V. Sukhatme,et al.  Endostatin Induces Endothelial Cell Apoptosis* , 1999, The Journal of Biological Chemistry.

[9]  K. Rubin,et al.  Signaling via fibroblast growth factor receptor-1 is dependent on extracellular matrix in capillary endothelial cell differentiation. , 1999, Experimental cell research.

[10]  T. L. Moser,et al.  Angiostatin binds ATP synthase on the surface of human endothelial cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[11]  N. Welsh,et al.  Transgenic Mice Expressing Shb Adaptor Protein under the Control of Rat Insulin Promoter Exhibit Altered Viability of Pancreatic Islet Cells , 1999, Molecular medicine.

[12]  L. Hlatky,et al.  Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy. , 1998, Cancer research.

[13]  J. Shiloach,et al.  Zinc-binding of endostatin is essential for its antiangiogenic activity. , 1998, Biochemical and biophysical research communications.

[14]  R. Timpl,et al.  Zinc-dependent dimers observed in crystals of human endostatin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K. Kullander,et al.  The Src homology 2 domain protein Shb transmits basic fibroblast growth factor- and nerve growth factor-dependent differentiation signals in PC12 cells. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[16]  R. Timpl,et al.  Structure, function and tissue forms of the C‐terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin , 1998, The EMBO journal.

[17]  J. Folkman,et al.  Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  R. Timpl,et al.  Crystal structure of the angiogenesis inhibitor endostatin at 1.5 Å resolution , 1998, The EMBO journal.

[19]  L. Cantley,et al.  Stimulation through the T cell receptor leads to interactions between SHB and several signaling proteins , 1998, Oncogene.

[20]  Thomas Boehm,et al.  Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.

[21]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[22]  M. Welsh,et al.  Apoptosis of NIH3T3 cells overexpressing the Src homology 2 domain protein Shb. , 1996, Oncogene.

[23]  S. Kanda,et al.  Fibroblast growth factor receptor 1-induced differentiation of endothelial cell line established from tsA58 large T transgenic mice. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[24]  T. Quertermous,et al.  Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[26]  T. Pihlajaniemi,et al.  Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Seldin,et al.  Cloning of cDNA and genomic DNA encoding human type XVIII collagen and localization of the alpha 1(XVIII) collagen gene to mouse chromosome 10 and human chromosome 21. , 1994, Genomics.

[28]  L. Claesson‐Welsh,et al.  The platelet-derived growth factor beta-receptor kinase insert confers specific signaling properties to a chimeric fibroblast growth factor receptor. , 1992, The Journal of biological chemistry.

[29]  N. Ferrara,et al.  The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. , 1991, Endocrinology.

[30]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.

[31]  J. Folkman,et al.  How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. , 1986, Cancer research.

[32]  J. A. Matthews,et al.  Enhanced chemiluminescent method for the detection of DNA dot-hybridization assays. , 1985, Analytical biochemistry.

[33]  J. Williams,et al.  Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth. , 1985, The American journal of pathology.

[34]  V. Sukhatme,et al.  Endostatin: yeast production, mutants, and antitumor effect in renal cell carcinoma. , 1999, Cancer research.

[35]  V. M. Heatwole.  TUNEL assay for apoptotic cells. , 1999, Methods in molecular biology.

[36]  C. Reutelingsperger,et al.  Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. , 1998, Cytometry.

[37]  Y. Cao,et al.  Endogenous angiogenesis inhibitors: angiostatin, endostatin, and other proteolytic fragments. , 1998, Progress in molecular and subcellular biology.

[38]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[39]  J. Mares,et al.  Shb is a ubiquitously expressed Src homology 2 protein. , 1994, Oncogene.